Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:44 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 385 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Hip Arthrosis Clear all

Conditions: Osteoarthritis of the Hip
Interventions: Resonator device; Device
Lead sponsor: pico-tesla Magnetic Therapies, LLC; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Clearwater, Florida

Conditions: Femoroacetabular Impingement Syndrome, Acetabular Labral Tear
Interventions: Hip brace; Device
Lead sponsor: University of Washington; Other
Eligibility: 14 Years to 60 Years
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Arthroplasty, Replacement, Hip
Interventions: Tritanium® Primary Acetabular Shell; Device
Lead sponsor: Stryker Orthopaedics; Industry
Eligibility: 18 Years and older
Enrollment: 275 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2023
U.S. locations: 7
States / cities: St. Helena, California • Tampa, Florida • Lexington, Kentucky + 4 more

Conditions: Non-inflammatory Degenerative Joint Disease, Osteoarthritis, Avascular Necrosis, Post-traumatic Arthritis
Interventions: Ceramax Acetabular System; Device
Lead sponsor: DePuy Orthopaedics; Industry
Eligibility: Not listed
Enrollment: 185 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 12
States / cities: Sacramento, California • Denver, Colorado • Fort Collins, Colorado + 8 more

Conditions: Knee Osteoarthritis, Hip Osteoarthritis, Knee Arthritis, Hip Arthritis
Interventions: Total knee or Hip Arthroplasty; Procedure
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Chronic Pain
Interventions: Tramadol HCl ER; Drug
Lead sponsor: Bausch Health Americas, Inc.; Industry
Eligibility: 18 Years to 74 Years
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2003
U.S. locations: 1
States / cities: Duncansville, Pennsylvania

Conditions: Osteoarthritis
Interventions: Coping skills training (CST) for chronic pain, Usual care; Behavioral · Other
Lead sponsor: Stony Brook University; Other
Eligibility: 21 Years and older
Enrollment: 257 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 3
States / cities: Setauket, New York • Smithtown and Port Jefferson, New York • Danville, Virginia

Conditions: Control of Frontal Plane Biomechanics, Patellofemoral Pain Syndrome
Interventions: Hip Activation, Hip activation + Single leg balance; Other
Lead sponsor: Louisiana State University Health Sciences Center Shreveport; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Shreveport, Louisiana

Conditions: Femoro Acetabular Impingement, Pain, Postoperative
Interventions: Warmed Arthroscopic Fluids, Room Temperature Arthroscopic Fluids; Procedure
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 65 Years
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Englewood, Colorado

Conditions: Osteoarthritis, Arthritis, Joint Diseases, Musculoskeletal Diseases, Rheumatic Diseases
Interventions: Total Hip Replacement; Device
Lead sponsor: Anderson Orthopaedic Research Institute; Other
Eligibility: Not listed
Enrollment: 236 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2012
U.S. locations: 1
States / cities: Alexandria, Virginia

Conditions: Osteo Arthritis Knee, Osteoarthritis, Hip
Interventions: OA Care Plan; Other
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 40 Years to 99 Years
Enrollment: 5,713 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Hip Dysplasia
Interventions: Periacetabular osteotomy, Periacetabular osteotomy with hip arthroscopy; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 15 Years to 55 Years
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2028
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Femoracetabular Impingement
Interventions: Not listed
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 14 Years to 40 Years
Enrollment: 747 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 10
States / cities: Aurora, Colorado • Iowa City, Iowa • Boston, Massachusetts + 7 more

Conditions: Femoroacetabular Impingement, Acetabular Dysplasia, Acetabular Labrum Tear, Hip Pain, Rehabilitation
Interventions: Not listed
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 15 Years to 40 Years
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Osteoarthritis, Pain
Interventions: Placebo, Fulranumab 1 mg, Fulranumab 3 mg, Celecoxib 100 mg, Celecoxib 100 mg Matching Placebo; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 111 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 32
States / cities: Glendale, Arizona • Phoenix, Arizona • Tucson, Arizona + 29 more

Conditions: Arthritis, Osteoarthritis, Osteoarthritis, Hip
Interventions: tanezumab, Placebo; Biological
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 627 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 99
States / cities: Mobile, Alabama • Paradise Valley, Arizona • Peoria, Arizona + 74 more

Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip
Interventions: Celecoxib; Drug
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 875 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 67
States / cities: Huntsville, Alabama • Peoria, Arizona • Phoenix, Arizona + 58 more

Conditions: Arthroplasty, Replacement, Hip
Interventions: Accolade® TMZF® Hip Stem; Device
Lead sponsor: Stryker Orthopaedics; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 241 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2014
U.S. locations: 11
States / cities: Newport Beach, California • San Diego, California • Boynton Beach, Florida + 8 more

Conditions: Hip Pain Chronic, Hip Impingement Syndrome, Hip Injuries, Blood Loss, Femoro Acetabular Impingement
Interventions: Tranexamic acid, Placebo; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Osteoarthritis
Interventions: Mini-Posterior surgical approach for total hip arthroplasty, Direct Anterior surgical approach for total hip arthroplasty; Procedure
Lead sponsor: OrthoCarolina Research Institute, Inc.; Other
Eligibility: 25 Years to 80 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Joint Diseases
Interventions: 28 mm ceramic head on ceramic acetabular liner., 28 mm ceramic head on polyethylene liner; Device
Lead sponsor: DePuy Orthopaedics; Industry
Eligibility: 20 Years to 75 Years
Enrollment: 264 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2012
U.S. locations: 2
States / cities: Denver, Colorado • Columbus, Ohio

Conditions: Osteoarthritis, Hip, Complications; Arthroplasty
Interventions: Revelation Hip Stem (Revelation); Device
Lead sponsor: Encore Medical, L.P.; Industry
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Osteoarthritis, Hip
Interventions: EOS X-Ray; Diagnostic Test
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 99 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Osteoarthritis, Rheumatoid Arthritis, Post Traumatic Arthritis
Interventions: KINCISE(TM) Surgical Automated System; Device
Lead sponsor: DePuy Orthopaedics; Industry
Eligibility: 21 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 11
States / cities: Roseville, California • Denver, Colorado • Albany, New York + 6 more

Search by objective public record fields.

Low Level Magnetic Fields for the Treatment of Osteoarthritis of the Hip

Postoperative Hip Bracing After Hip Arthroscopy

Tritanium® Primary Acetabular Shell Study

28mm Ceramic-on-Ceramic Total Hip Replacement Study

An Analysis of the Outcomes From Protocolized Perioperative Care for Patients Receiving Total Hip or Knee Arthroplasty

A Study Comparing the Effectiveness and Safety of Varying Dose Strengths (100, 200, 300 and 400 mg) of Extended-release Tramadol HCl With Placebo for the Treatment of Osteoarthritis(OA) of the Knee and/or Hip

Effectiveness of a Training Program in Improving Coping Skills in People With Arthritis Pain

Impact of Hip Activation Compared to Hip Plus Balance Training on the Forward-Step-Down Test

Effect of Warmed Irrigation in Hip Arthroscopy Undergoing Hip Arthroscopy

Study Comparing Marathon Polyethylene and Enduron Polyethylene Acetabular Liners Used in Total Hip Arthroplasty

Development of an Osteoarthritis (OA) Care Plan to Improve Process and Quality of OA Treatment Decisions

Clinical Trial of Concomitant Hip Arthroscopy During PAO

Identification of Predictors for Clinical Outcomes in Femoroacetabular Impingement Surgery

Healthy Hip Study: Conservative Management for Pre-arthritic Hip Disorders

Study of Safety, Efficacy of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3007

Tanezumab in Osteoarthritis Of The Hip

Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use"

Accolade® TMZF® Hip Stem Outcomes Study

Tranexamic Acid (TXA) in Hip Arthroscopy

A Trial Comparing Mini-posterior Approach and Direct Anterior Approach

28 mm Ceramic-on-Ceramic Acetabular Cup Total Hip Replacement Study

Encore Revelation Hip Stem

Variability in Spinopelvic Parameters Among Patients Undergoing Total Hip Arthroplasty

Anterior Advantage With KINCISE